[Facial angioedema following hyaluronic acid injection].
F
F
Stephan
I
I
Maatouk
R
R
Moutran
G
G
Obeid
D000799:Angioedema / Q000139:chemically induced* / Q000188:drug therapy; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology*; D004359:Drug Therapy, Combination; D005148:Facial Dermatoses / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D039563:Histamine H1 Antagonists, Non-Sedating / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000009:adverse effects; D007271:Injections, Intradermal; D008012:Lidocaine / Q000008:administration & dosage; D008047:Lip Diseases / Q000139:chemically induced / Q000188:drug therapy; D017336:Loratadine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications; D015595:Skin Aging / Q000187:drug effects; D012882:Skin Tests
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D039563:Histamine H1 Antagonists, Non-Sedating; C526061:Juvederm Ultra; D017336:Loratadine; D006820:Hyaluronic Acid; D008012:Lidocaine; C121345:desloratadine; D011241:Prednisone